Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

Cited In for PubMed (Select 15536230)

1.

Neural control of energy balance: translating circuits to therapies.

Gautron L, Elmquist JK, Williams KW.

Cell. 2015 Mar 26;161(1):133-45. doi: 10.1016/j.cell.2015.02.023. Review.

PMID:
25815991
2.

Comparison of results from different imputation techniques for missing data from an anti-obesity drug trial.

Jørgensen AW, Lundstrøm LH, Wetterslev J, Astrup A, Gøtzsche PC.

PLoS One. 2014 Nov 19;9(11):e111964. doi: 10.1371/journal.pone.0111964. eCollection 2014.

3.

Pharmacotherapy for obesity: novel agents and paradigms.

Manning S, Pucci A, Finer N.

Ther Adv Chronic Dis. 2014 May;5(3):135-48. doi: 10.1177/2040622314522848. Review.

4.

Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity.

Jordan J, Astrup A, Engeli S, Narkiewicz K, Day WW, Finer N.

J Hypertens. 2014 Jun;32(6):1178-88. doi: 10.1097/HJH.0000000000000145. Review.

5.

Teledietetics improves weight reduction by modifying eating behavior: a randomized controlled trial.

Chung LM, Law QP, Fong SS, Chung JW.

Telemed J E Health. 2014 Jan;20(1):55-62. doi: 10.1089/tmj.2013.0104. Epub 2013 Nov 8.

6.
7.

Antiobesity pharmacotherapy: new drugs and emerging targets.

Kim GW, Lin JE, Blomain ES, Waldman SA.

Clin Pharmacol Ther. 2014 Jan;95(1):53-66. doi: 10.1038/clpt.2013.204. Epub 2013 Oct 8. Review.

8.

Topiramate: Effects on cognition in patients with epilepsy, migraine headache and obesity.

Sommer BR, Mitchell EL, Wroolie TE.

Ther Adv Neurol Disord. 2013 Jul;6(4):211-27. doi: 10.1177/1756285613481257.

9.

Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity.

Shin JH, Gadde KM.

Diabetes Metab Syndr Obes. 2013 Apr 8;6:131-9. doi: 10.2147/DMSO.S43403. Print 2013.

10.

Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP).

Allison DB, Gadde KM, Garvey WT, Peterson CA, Schwiers ML, Najarian T, Tam PY, Troupin B, Day WW.

Obesity (Silver Spring). 2012 Feb;20(2):330-42. doi: 10.1038/oby.2011.330. Epub 2011 Nov 3.

11.

Behavioral and pharmacologic therapies for obesity.

Vetter ML, Faulconbridge LF, Webb VL, Wadden TA.

Nat Rev Endocrinol. 2010 Oct;6(10):578-88. doi: 10.1038/nrendo.2010.121. Epub 2010 Aug 3. Review.

12.

Topiramate in the treatment of substance-related disorders: a critical review of the literature.

Shinn AK, Greenfield SF.

J Clin Psychiatry. 2010 May;71(5):634-48. doi: 10.4088/JCP.08r04062gry. Epub 2010 Mar 9. Review.

13.

Zonisamide decreases ethanol intake in rats and mice.

Knapp CM, Mercado M, Markley TL, Crosby S, Ciraulo DA, Kornetsky C.

Pharmacol Biochem Behav. 2007 May;87(1):65-72. Epub 2007 Apr 11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk